Illumina Body Map 2: averaged replicates
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SREBF2 | hg19_v2_chr22_+_42229100_42229146 | 0.15 | 4.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_56150184 Show fit | 4.76 |
ENST00000394554.1
|
EGF containing fibulin-like extracellular matrix protein 1 |
|
chr12_-_53343602 Show fit | 4.03 |
ENST00000546897.1
ENST00000552551.1 |
keratin 8 |
|
chr6_+_151561085 Show fit | 3.37 |
ENST00000402676.2
|
A kinase (PRKA) anchor protein 12 |
|
chr12_-_53343633 Show fit | 3.26 |
ENST00000546826.1
|
keratin 8 |
|
chr9_+_96928516 Show fit | 3.16 |
ENST00000602703.1
|
RP11-2B6.3 |
|
chr12_-_91505608 Show fit | 3.01 |
ENST00000266718.4
|
lumican |
|
chr12_-_53343560 Show fit | 2.91 |
ENST00000548998.1
|
keratin 8 |
|
chr7_-_84816122 Show fit | 2.78 |
ENST00000444867.1
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
|
chr19_+_55591743 Show fit | 2.68 |
ENST00000588359.1
ENST00000245618.5 |
EPS8-like 1 |
|
chr6_-_32152064 Show fit | 2.51 |
ENST00000375076.4
ENST00000375070.3 |
advanced glycosylation end product-specific receptor |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 10.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
2.5 | 7.4 | GO:1904603 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.5 | 4.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.1 | 3.4 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.2 | 3.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 3.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.3 | 3.0 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.0 | 2.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 2.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 2.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 10.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 6.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 5.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 4.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 2.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 2.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.6 | 1.9 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.1 | 1.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 1.7 | GO:0043218 | compact myelin(GO:0043218) |
0.5 | 1.6 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
2.5 | 7.4 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
1.0 | 4.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.8 | 3.4 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.2 | 3.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 3.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 2.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 2.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 2.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 7.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 6.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 6.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 3.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 7.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 4.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 3.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 1.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |